Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
6.5M
-
Shares change
-
+34.4K
-
Total reported value, excl. options
-
$305M
-
Value change
-
+$451K
-
Put/Call ratio
-
9.18
-
Number of buys
-
74
-
Number of sells
-
-68
-
Price
-
$46.80
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2017
181 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2017.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.5M shares
of 22.3M outstanding shares and own 29.16% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.16M shares), VANGUARD GROUP INC (477K shares), GLENMEDE TRUST CO NA (399K shares), FIRST MANHATTAN CO (376K shares), DIMENSIONAL FUND ADVISORS LP (339K shares), RENAISSANCE TECHNOLOGIES LLC (297K shares), STATE STREET CORP (296K shares), MANGROVE PARTNERS (280K shares), NOMURA HOLDINGS INC (209K shares), and DEUTSCHE BANK AG\ (170K shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.